Myocardial calcium signaling in physiology and disease
Soojeong Kang,1 Djamel Lebeche1,2
1Cardiovascular Research Institute, 2Graduate School of Biological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Abstract: It is now well-established that calcium (Ca2+) is a critical regulator of myocardial function and that abnormalities in cardiomyocyte intracellular Ca2+ dynamics contribute to pathophysiologic changes observed in several cardiac diseases, including cardiac hypertrophy, chronic heart failure, and ventricular tachyarrhythmias. Although Ca2+ plays a key role in maintaining cardiac excitation–contraction coupling, it is increasingly apparent that changes in myocardial Ca2+ also contribute to the regulation of normal and pathological signal transduction that controls myocyte growth, hypertrophic signaling, mitochondrial energetics, and transcriptional gene expression. Interestingly, experimental evidence suggests that these multifarious Ca2+-dependent responses are spatially and temporally mediated by distinct cellular Ca2+ pools (ie, microdomains), which are generated by diverse channels and molecular signals with widely differing timescales of activation. These concepts are discussed in this review, as well as the emerging role of microRNAs in cardiac remodeling and myocardial Ca2+ dynamics.
Keywords: calcium signaling, calcium microdomains, hypertrophy, heart failure, arrhythmia, microRNAs
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]